Law firms
Investigation into MoonLake Immunotherapeutics for Potential Securities Law Violations
MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on treating inflammatory skin and joint diseases, is under investigation by leading securities law firm Bleichmar Fonti & Auld LLP for potential violations of federal securities laws. The investigation stems from disappointing results of the company's Phase 3 VELA trials for